The Company resolved to issue 3,000 Series 20 share acquisition rights free of charge as stock options to 4 of its directors. If all are exercised, 300,000 common shares will be delivered, resulting in maximum dilution of 0.47%.
Issuance of Share Acquisition Rights as Stock Options (株式会社ステムリム Series 20 Share Acquisition Rights)
300,000 common shares (3,000 share acquisition rights, 100 shares per right)
Free of charge
Maximum 0.47% (based on 62,681,200 issued shares as of 9 September 2026)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of Share Acquisition Rights as Stock Options (株式会社ステムリム Series 20 Share Acquisition Rights) |
| Number of shares to be issued or disposed of | 300,000 common shares (3,000 share acquisition rights, 100 shares per right) |
| Issue price and disposal price | Free of charge |
| Total issue value | Free of charge |
| Intended allottee | Name The Company's directors (including outside directors) / Number of Employees 4 / Number of stock acquisition rights 3,000 stock acquisition rights |
| Intended allottee's holding policy | The transfer of the share acquisition rights requires approval from the Company's Board of Directors. |
| Dilution Rate | Maximum 0.47% (based on 62,681,200 issued shares as of 9 September 2026) |
| Total number of issued shares | 62,681,200 shares → Not disclosed |
| Basis for determining the amount to be paid | The exercise price is the closing price of the Company's common shares in regular trading on the Tokyo Stock Exchange on the allotment date multiplied by 1.025. The premium to the closing price is 2.5%. |
| Exercise price | Closing price on the allotment date × 1.025 (fractions of less than ¥1 rounded up). Adjusted for share splits or consolidations, the issuance of new shares or disposal of treasury shares at a price below market value, organizational restructurings and other events. The lower limit is Not disclosed. |
| Exercise period | Start Date 11 September 2028 / End date 9 September 2036 |
| Number of Stock Acquisition Rights | Total number issued 3,000 stock acquisition rights / Number of unexercised units Not disclosed |
| Reason for acquisition without consideration | If a merger in which the Company is the disappearing company, or a share exchange or share transfer in which the Company becomes a wholly owned subsidiary, is approved at a shareholders meeting. If a holder of the share acquisition rights no longer meets the exercise conditions or waives the rights. The Company may cancel the share acquisition rights it has acquired and holds at any time free of charge. |
| Categories and Number of Persons Covered | 4 of the Company's directors (including outside directors), 3,000 rights |
| Total Stock-Based Compensation | The annual limit on share acquisition rights compensation for directors is ¥150 million, including ¥30 million for outside directors. The amount granted on this occasion is Not disclosed. |
| Procedures under the Corporate Code of Conduct | At the 16th Annual Shareholders Meeting held on 27 October 2021, approval was obtained for the amount and terms of stock option compensation for directors and audit & supervisory board members. This issuance was resolved by the Board of Directors at its meeting held on 9 September 2026. Whether an independent third-party opinion was obtained is Not disclosed. |
| Impact on Business Performance | To increase motivation and morale to contribute to advances in research and development and contribute to higher corporate value. The specific amount of the impact on performance is Not disclosed. |
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
To increase motivation and morale to contribute to advances in research and development and provide incentive compensation that contributes to higher corporate value. The Company recognizes that the impact of dilution is within a reasonable range.